Addendum. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S19-S40.
作者信息
ElSayed Nuha A, Aleppo Grazia, Aroda Vanita R, Bannuru Raveendhara R, Brown Florence M, Bruemmer Dennis, Collins Billy S, Hilliard Marisa E, Isaacs Diana, Johnson Eric L, Kahan Scott, Khunti Kamlesh, Leon Jose, Lyons Sarah K, Perry Mary Lou, Prahalad Priya, Pratley Richard E, Seley Jane Jeffrie, Stanton Robert C, Gabbay Robert A
出版信息
Diabetes Care. 2023 Sep 1;46(9):1715. doi: 10.2337/dc23-ad08.
Abstract
摘要
相似文献
1
Addendum. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S19-S40.
Diabetes Care. 2023 Sep 1;46(9):1715. doi: 10.2337/dc23-ad08.
2
Erratum. 2. Classification and diagnosis of diabetes: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S19-S40.
Diabetes Care. 2023 May 1;46(5):1106. doi: 10.2337/dc23-er05.
3
Addendum. 2. Classification and Diagnosis of Diabetes: . Diabetes Care 2021;44(Suppl. 1):S15-S33.
Diabetes Care. 2021 Sep;44(9):2182. doi: 10.2337/dc21-ad09. Epub 2021 Jun 16.
4
Addendum. 7. Diabetes Technology: . Diabetes Care 2020;43(Suppl. 1):S77-S88.
Diabetes Care. 2020 Aug;43(8):1981. doi: 10.2337/dc20-ad08c. Epub 2020 Jun 5.
5
Addendum. 8. Obesity Management for the Treatment of Type 2 Diabetes: . Diabetes Care 2020;43(Suppl. 1):S89-S97.
Diabetes Care. 2020 Aug;43(8):1980. doi: 10.2337/dc20-ad08b. Epub 2020 Jun 5.
6
Addendum. 3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S41-S48.
Diabetes Care. 2023 Sep 1;46(9):1716-1717. doi: 10.2337/dc23-ad08a.
7
Addendum. 11. Microvascular Complications and Foot Care: : Diabetes Care 2021;44(Suppl. 1):S151-S167.
Diabetes Care. 2021 Sep;44(9):2186-2187. doi: 10.2337/dc21-ad09b. Epub 2021 Jun 16.
8
Addendum. 10. Cardiovascular Disease and Risk Management: . Diabetes Care 2021;44(Suppl. 1):S125-S150.
Diabetes Care. 2021 Sep;44(9):2183-2185. doi: 10.2337/dc21-ad09a. Epub 2021 Jun 16.
9
Addendum. 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45(Suppl. 1):S144-S174.
Diabetes Care. 2022 Sep 1;45(9):2178-2181. doi: 10.2337/dc22-ad08.
10
Addendum. 9. Pharmacologic Approaches to Glycemic Treatment: . Diabetes Care 2020;43(Suppl. 1):S98-S110.
Diabetes Care. 2020 Aug;43(8):1979. doi: 10.2337/dc20-ad08a. Epub 2020 Jun 5.
引用本文的文献
1
Global Research Trends in Artificial Intelligence and Type 2 Diabetes Mellitus: A Bibliometric Perspective.
Cureus. 2025 Jul 16;17(7):e88114. doi: 10.7759/cureus.88114. eCollection 2025 Jul.
2
Predicting the risk of lean non-alcoholic fatty liver disease based on interpretable machine models in a Chinese T2DM population.
Front Endocrinol (Lausanne). 2025 Jul 11;16:1626203. doi: 10.3389/fendo.2025.1626203. eCollection 2025.
3
Synergistic effects of NF-κB1 and inflammatory pathway polymorphisms on hypertension and dyslipidemia susceptibility in type 2 diabetes.
Diabetol Metab Syndr. 2025 Jul 16;17(1):269. doi: 10.1186/s13098-025-01861-y.
4
Association Between Stress Hyperglycemia Ratio and Parkinson's Disease Across Different Glucose Metabolism Statuses-A Prospective Study From UK Biobank.
Eur J Neurol. 2025 Jul;32(7):e70299. doi: 10.1111/ene.70299.
5
Type 1 diabetes mellitus patients had lower total vitamin K levels and increased sensitivity to direct anticoagulants.
PLoS One. 2025 Jun 23;20(6):e0326580. doi: 10.1371/journal.pone.0326580. eCollection 2025.
6
Short-Chain Fatty Acids Are Potential Biomarkers of Immune Regulation in Diabetic Retinopathy.
Invest Ophthalmol Vis Sci. 2025 Jun 2;66(6):23. doi: 10.1167/iovs.66.6.23.
7
Involvement of impaired carnitine-induced fatty acid oxidation in experimental and human diabetic kidney disease.
JCI Insight. 2025 May 22;10(13). doi: 10.1172/jci.insight.179362. eCollection 2025 Jul 8.
8
Gallstones in the Era of Metabolic Syndrome: Pathophysiology, Risk Prediction, and Management.
Cureus. 2025 Mar 13;17(3):e80541. doi: 10.7759/cureus.80541. eCollection 2025 Mar.
9
Prevalence and Clinical Characteristics of NEUROD1-MODY in Chinese Early-Onset Type 2 Diabetes Mellitus and a Literature Review.
J Diabetes. 2025 Apr;17(4):e70080. doi: 10.1111/1753-0407.70080.
10
First-in-Human Side-to-Side Duodeno-Ileal Bipartition for Weight Loss and Type 2 Diabetes with the Swallowable Biofragmentable Magnetic Anastomosis System.
J Am Coll Surg. 2025 Mar 10. doi: 10.1097/XCS.0000000000001384.
本文引用的文献
1
Familiality of diabetes mellitus.
Exp Clin Endocrinol Diabetes. 2007 Nov;115(10):634-40. doi: 10.1055/s-2007-984443.
2
Family history and risk of type 1 diabetes mellitus.
Acta Diabetol. 2002 Sep;39(3):111-5. doi: 10.1007/s005920200028.
Zotero 插件